A broad spectroscopic characterization, using ultraviolet-visible (UV-vis) and Fourier transform infrared absorption as well as Raman scattering, of two commonly used anthracyclines antibiotics (DOX) daunorubicin (DNR), their epimers (EDOX, EDNR) and ten selected analogs is presented. The paper serves as a comprehensive spectral library of UV-vis, IR and Raman spectra of anthracyclines in the solid state and in solution. The particular advantage of Raman spectroscopy for the measurement and analysis of individual antibiotics is demonstrated. Raman spectroscopy can be used to monitor the in vitro uptake and distribution of the drug in cells, using both 488 nm and 785 nm as source wavelengths, with submicrometer spatial resolution, although the cellular accumulation of the drug is different in each case. The high information content of Raman spectra allows studies of the drug-cell interactions, and so the method seems very suitable for monitoring drug uptake and mechanisms of interaction with cellular compartments at the subcellular level.
Introduction
Anthracyclines are a group of compounds, discovered over 50 years ago, which exhibit cytostatic activity and are used widely in anticancer treatment [1] . The first anthracycline isolated was daunorubicin (also called daunomycin), obtained from a bacterial strain of Streptomyces peucetius [2, 3] . Another anthracycline also widely used in oncology is doxorubicin (Adriamycin ® ) [4] .
Anthracyclines have tetracycline ring structures with a daunosamine group attached by a glycosidic linkage. They are multifunctional derivatives of anthraquinone and are composed of aglycone (4 rings connected to each other -A, B, C, D) and the sugar moiety ( Figure 1A ).
The structure of 7-Deoxydaunorubicinone (7-Deoxy daunorubicinaglycone; DNR-ON) is presented in Figure 1B . Ring B of aglycone is a hydroquinone skeleton and ring C-a quinone group. At the C-4 position of the D-ring, a methoxy group is attached. To an A-ring at the C-9 position, a sugar moiety (daunosamine) is connected via a glycosidic bond at the C-7 position.
Daunosamine is derived from 3-amino-2,3,6-trideoxy-L-fructose. The only structural difference between doxorubicin (DOX) and daunorubicin (DNR) is that the side chain of DOX terminates with a primary alcohol (C14), whereas that of DNR terminates with a methyl group [1] . Chemical structures of DOX and DNR are presented in Figure 1A . This small structural difference between DOX and DNR has significant impact on the activity and cytotoxicity of these anthracyclines [1, 5] . DNR antitumor activity led to an intensive search for analogs/derivatives compounds, which elicit comparable therapeutic effect but lesser cardiotoxity and vasotoxicity [6] . Within this group of compounds are included DOX and DNR epimers -epidoxorubicin (EDOX) and epidoxorubicin (EDOX) and epidaunorubicin (EDNR; not yet used in the treatment of cancer, EDNR) are semi-synthetic derivatives of DNR and DOX, respectively, obtained by epimerization of the hydroxyl group at C-4' in the daunosamine structure from equatorial to axial positions. Chemical structures of both isomers are shown in Figure 1 .A. EDOX is an analog of the second generation, which has been proposed as an alternative to DOX with lower toxicity [7] . Despite the broad and relatively established usage of DNR, DOX, EDOX in antitumor therapy, their mechanism of action is still not fully understood. Anthracyclines belong to the anticancer cycle-dependent and phase-specific drugs [1] . They have a complex mechanism of action, which includes: intercalation into DNA, inhibition of the synthesis of macromolecules, formation of bonds between the nitrogenous bases of DNA, DNA alkylation, DNA crosslinking, inhibition of topoisomerase I and II -key enzymes in DNA synthesis, and formation of free radicals, which damage DNA and lead to lipid peroxidation [1, 8] . Initiation of DNA damage through the inhibition of topoisomerase II, leading to the apoptosis, is believed to be a dominant mechanism of therapeutic action of the anthracyclines [8] [9] [10] as well as of their cardiotoxicity mediated by topoisomerase-IIβ in cardiomyocytes [11] . Topoisomerases are enzymes, which cause the double helix of DNA to be untangled or unwound, a process which is necessary for DNA replication and transcription. Inhibition of topoisomerase II in cancer cells consists of the formation of the complex of anthracycline-DNA-topoisomerase II, resulting in DNA fragmentation and, as a consequence, in the inhibition of cellular proliferation and cell death [1, 8, 9] . Anthracycline therapy is complicated by its cardiotoxicity, which can in some cases lead to symptomatic heart failure, and even death caused by cardiac diseases (Torti et al. 1986 active anti-cancer therapy (so called early cardiotoxicity), within one year after the end of treatment, and many years after the end of therapy with anthracyclines [18, 19] .
Cardiotoxicity and side effects of anthracycline therapy spurred researchers worldwide to explore analogs/derivatives of the parent drugs, especially since EDOX and EDNR have demonstrated improved performance in terms of balance of antitumor active versus cardiotoxicity. Modifications in the chemical structure by, for example replacement of the-NH 2 moiety at position 3' in daunosamine by a formamidine group (-N=CH-NR 1 R 2 ), which includes other cyclic amines of gradually increased ring size, for example piperidine [20, 21] lead to the formation of new and promising anthracycline analogs (formamidinoanthracyclines). Chemical structures of these selected derivatives are also presented in Figure 1 .A. It has been shown that these new derivatives of anthracyclines exhibit lower toxicity and cardiotoxicity, together with an ability to overcome the barrier of drug resistance in vitro, as well as high anticancer activity in comparison to the parent compounds (DNR, DOX, EDNR and EDOX) [10, 20, 22] . Another interesting analog of anthracycline antibiotics is a derivative of DNR -oxazolinodaunorubicin (DNR-OXZL) [23] .
DNR-OXZL contains an oxazoline ring connected to the daunosamine moiety and seems to display improved properties (higher anticancer efficacy, lower cardiotoxicity, etc.) than DNR [23] .
As these new compounds emerge, it is important to effectively characterize their structures, but also their efficacies and mechanisms of interaction and ultimately generate quantitative structure activity relationships, as a basis for predictive toxicological models to guide synthetic strategy. Anthracyclines, especially DNR and DOX have been widely investigated using various spectroscopic methods, e.g. Raman spectroscopy [24, 25] , Resonance Raman (RR) [26] [27] [28] , Surface Enhanced Raman Spectroscopy (SERS) [29] [30] [31] [32] , UV-Vis absorption [26, 33] and FT-IR absorption spectroscopy [24, 34, 35] . The visible absorption spectra of DOX and DNR are, however, almost identical, having a maximum of absorption near to 480-490 nm.
Vibrational spectroscopy seems to be the most appropriate technique to better understand the molecular chemical structures and the interactions of these compounds with DNA [29, 36] .
The strong visible absorption maxima can be easily used to exploit the benefits of resonance enhancement in Raman spectroscopy. The resonance and pre-resonance Raman spectra of DOX and DNR are related to the first electronic band at 480 nm and complete band assignments have been documented [27, 28] .
Over the past decades, the potential of vibrational spectroscopy for biomedical applications has been well established [37] [38] [39] [40] . Raman spectroscopy coupled with confocal microscopy has a great potential for biomedical and biopharmaceutical applications due to ability of noninvasive, label-free detection of cellular changes at single cell level and imaging biomolecule distribution in an individual cell [41, 42] . The high information content of Raman spectra can be used to characterize drug-cell interactions [43, 44] and therefore serve as a suitable tool for drug screening.
In this paper, we present spectroscopic characterization (UV-vis, FT-IR, Raman (RS) and
Resonance Raman (RRS) spectroscopies) of the most common anthracyclines (DOX, DNR), their epimers (EDOX, EDNR) and ten selected analog (four morpholine (-FMOR) compounds, four piperidine (-FPIP) compounds, one hexamethyleneimine derivative of DNR (DNR-FHEX) and oxazolinodaunorubicin (DNR-OXZL)). This work shows the potential of Raman spectroscopy for the measurement and analysis of such a large collection of individual and structurally similar anthracycline antibiotics and their analogs. It can serve as a comprehensive vibrational spectral library, based on previously reported UV-vis, IR and Raman measurements. Several reviews have previously been resented (e.g. [24, 27, 45, 46] 
showing the potential of Raman spectroscopy, but they were mostly based on the resonance effect, (and IR spectroscopy [24] ) for the measurement and analysis of DOX and DNR.
However, to the best of our knowledge, such a large collection of individual anthracycline compounds Raman spectra has not been provided and discussed in any paper. Additionally, Raman spectroscopy, can be used to monitor the in vitro uptake and distribution of drug carrier systems and the drug itself [47] . Here, we present the approach that comprises full spectral characterization of several chemotherapeutic agents and in vitro subcellular tracking of a known anthracycline compound (DOX) based on its unique spectral features.
Experimental

Anthracyclines samples
All investigated anthracycline compounds, of purity>97.5 % as determined using HPLC, were synthesized in the Institute of Biotechnology and Antibiotics, Warsaw, Poland and synthetized as described previously [20, 22] .
Cell culture
EA.hy926 cells were cultured at 37°C and 5% CO 2 in Dulbecco's modified Eagle's medium (DMEM, Lonza) supplemented with 10% fetal bovine serum (FBS),1% penicillinstreptomycin, 2 mM L-Glutamine (Invitrogen) and 2% HAT medium supplement. The cell cultures were incubated in a 37 °C, 5% CO 2 /95% air, humidified cell culture incubator and passaged three times a week. For Raman measurements, cells (EA.hy926) were cultivated on calcium fluoride slides (CaF 2 , 25×2 mm, Pike Technologies, U.S.) placed within wells of a 6well plate and fed with complete medium containing either no anthracycline (control) or1 µM DOX. After 24 hours, the cells were fixed with 2.5% glutaraldehyde (4 min) and stored in isotonic phosphate buffer (pH=7; 4 o C), until the start of data acquisition.
A549 human lung adenocarcinoma cells were cultured in DMEM supplemented with 2mM L-glutamine and 10% FBS at 37 °C in a humidified atmosphere containing 5% CO 2 and passaged every two days. For Raman measurements, cells (A549) were seeded on CaF 2 disks for 24hrs, after which medium was completely removed and cells were washed twice with PBS and fed with complete medium containing either no anthracycline (control) or 1 µM DOX. After 24 hours incubation, the cells were fixed with formalin (4%, 15 min) and kept in PBS until the start of measurement.
UV-vis spectroscopy
UV-vis spectra of sample solutions were measured in quartz cells with a path length of 1 cm in the 190-750 nm spectral range using a Perkin Elmer Lambda-35 spectrometer. UVvis spectra were recorded using a scanning speed of 480 nm min −1 with a 1 nm data interval.
FT-IR spectroscopy
FT-IR spectra of sample powders were obtained using a Bruker Alpha FT-IR spectrometer in Attenuated Total Reflection (ATR) mode, over the spectral range 400-4000 cm -1 . For optimal signal-to-noise ratio, 128 scans were averaged per sample spectrum and 256 scans per background spectrum.
Raman spectroscopy
Anthracyclines samples
Raman spectra were acquired using a WITec Raman microscope, with application of a 20x air objective (NA= 0.45). Two excitation wavelengths were used: 488 nm (spectral range: Pre-processing included cosmic spike removal and background subtraction was performed using Witec Project Plus software.
A549 human lung adenocarcinoma cells were measured using Horiba Jobin-Yvon LabRAM HR800 spectrometer with 785 nm laser as a source. Spectra were acquired using 100x objective (LCPlanN, Olympus) with integration time of 30 second per spectrum two times, from three cell locations: cytoplasm, nucleus and nucleolus, to finally produce a data set of 28 points per cell locations for each control and exposure to DOX cells.
Results and discussion
UV-vis spectroscopy
Spectral profiles of all UV-vis spectra shown are similar, with the exception of that of DNR-HEX (also DNR-OXZL and DNR-ON, due to use of different solvent), and the absorption spectra show maxima at 232, 252, 290 and 480 nm ( Figure 2 ). The maximum at 480 nm is assigned to a π-π * transition of the quinonoid structure [27] . The UV-Vis spectrum of DNR-HEX can be distinguished by higher intensity of the bands at 195 and 256 nm and the absence of the band at 290 nm. Although they do not provide an easily distinguishable spectral fingerprint of the specific compound, at the spectral profile is dominated by the conjugated electronic system, common to all compounds, UV-vis spectra give useful information in terms of choosing the source wavelength for Raman spectroscopy measurements. The Raman spectra of anthracyclines obtained with an excitation within the electronic band at 480 nm can result in resonance or pre-resonance. 
FT-IR spectroscopy
FT-IR spectra of 15 studied anthracyclines over the spectral range of 500-2000 cm -1 are presented in Figure 3 . A spectral signature of each anthracycline is clearly evident, and therefore it is possible to uniquely identify the investigated compounds. However, lack of sufficient literature data together with the complex molecular structure of anthracyclines encumbers the assignment of bands observed in acquired spectra. The assignment of spectral bands proposed here is made according to [24] . Detailed assignments of observed bands are listed in Table 1 , the most characteristic ones being highlighted. 
Raman spectroscopy
Non resonant Raman spectra of solid state anthracyclines were acquired with 785 nm source wavelength in the spectral range of 290-2000 cm -1 (Figure 4 ). They show characteristic spectral profiles with several marker bands ( Table 2 , the assignment of bands was performed based on literature [24, 27] ). Bands at ~344 cm -1 can be attributed to carbonyl coupled with ring bending [27] or ring bending and C-O-H wagging vibrations of the side chain of DOX [24] . The presence of this primary alcohol is the only structural difference between DOX and DNR as well as between EDOX and EDNR.
Strong bands at 444 and 462 cm -1 have comparable intensity in the DOX spectrum. Both can be assigned to ring and carbonyl group bending vibrations [24, 27] . The intensity ratio of the 444 and 462 cm -1 bands changes among the spectra of all investigated compounds. The 444 cm -1 band can be observed with a strong intensity for all anthracyclines except for EDOX, while the 462cm -1 band is diminished in spectra of EDNR and its derivatives, DNR, DNR-FMOR, EDOX-FPIP, DOX-FPIP and DOX-FMOR, although not so for EDOX. A weak band at 792 cm -1 is assigned to the ring bending vibration and C-H 3 wagging vibration of the daunosamine moiety [24] . This band is present in DOX, DNR and spectra of their derivatives.
However, it disappears for EDOX, EDNR and their derivatives. This can be correlated with the equatorial position of the hydroxyl group at C-4' in the daunosamine moiety. The band at this wavenumber is also not evident in the spectrum of DNR-ON (7-Deoxydaunorubicinone; a DNR derivative with no sugar moiety). Another characteristic band located at 1083 cm -1 is attributed to ring breathing and an aromatic carbon hydrogen bending, although an alternative assignment is to the methoxy carbon-oxygen stretch [27] . Hydroxyanthraquinones typically show two or three bands in the 1200-1300 cm -1 region due to coupled phenolic carbon-oxygen stretching and oxygen-hydrogen bending [28] . In the DOX spectrum, there are three bands present in this region at 1205, 1235 and 1290 cm -1 , all attributed to hydrogen bond bending vibrations (O-H … O) [24] . Additionally, bands at 1205 and 1290 cm -1 are assigned to ring vibration; bending of C-O-H groups contribute at 1235 cm -1 [24, 27] . All three bands are present in the Raman spectrum of each compound studied, suggesting a common origin.
Bands in the 1410-1455 cm -1 region can be assigned to aromatic ring vibrations [24] . There are three bands observed for DOX at 1413, 1428 and 1455 cm -1 , similar to DOX-FMOR, EDOX, DNR-FPIP and DNR-OXZL. However, spectra of other investigated compounds show one strong band at ~1440 cm -1 with a shoulder at ~1413 cm -1 in this region. Raman features at 1579 and 1643 cm -1 (DOX) originate from ring vibrations [24] . However, bands at 1428, 1455 and 1579 cm -1 can be assigned to aromatic C=C stretch coupled with stretch vibrations of hydrogen bonded carbonyl [27] . Similarly, a band located at 1643 cm -1 is attributed to hydrogen bonded stretching of C=O [27] . In terms of in vitro studies, studies of anthracyclines were used in a form of solutionin solubilised form are more appropriate, as they are exposed to, and uptaken by, the cells in this form. , and apposite Raman measurements were performed. For this purpose, water aqueous solutions of almost all investigated compounds were measured, except DNR-ON and DNR-OXZL, where for which DMSO was used as solvent. Raman spectra obtained for compounds studied in solution with a source wavelength of 785 nm ( Figure 5 ) share theexhibit comparable spectral profiles as to those obtained for the solid state anthracyclines (Figure 4 Generally, as can be seen in Table 2 , bands characteristic for anthracycline and their derivatives are mainly related to the highly polarizable ring derived vibrations and not the substituents themselves. The position of individual modes for investigated derivatives is shifted only a few cm -1 between the compounds. More significant changes are observed for FT-IR spectra. However, this method is limited when applied for in vitro study, as discussed later in Section 3.4. Figure 1S ) are dominated by fluorescence. The maximum of the fluorescence in DOX Raman spectrum at 4140 cm -1 (611 nm) corresponds to the maximum seen in DOX fluorescence spectra [27] . This maximum shifts to shorter wavelengths for EDOX, DNR-FPIP, DNR-FMOR and to higher wavelengths for the other investigated compounds. Resonance Raman spectrum of DOX ( 488 nm excitation wavelength) in water solution is, similarly, dominated by fluorescence ( Supplementary Materials, Figure 2S ).
This demonstrates a strong laser influence on the quality of Raman spectra of anthracyclines:
characteristic Raman bands of the solid state anthracyclines are clearly observed in spectra recorded by using 785 nm laser ( Figure 5 ). However, they are hardly seen when the 488 nm laser line is used as source due to the dominance of the fluorescence emission. On the other hand, both laser lines are suitable for in vitro investigation of anthracycline treated cells, as discussed in section 3.4.
Tracking of doxorubicin in vitro
The biological impact of DOX is broadly investigated and well described in literature, especially in the context of its interaction with DNA [26, 29] . The impact on cells of DOX exposure has been assessed in various in vitro tests [14, 17, [48] [49] [50] . Spectroscopic methods have also been employed to study the interactions in vitro [25, [51] [52] [53] . The development of a new therapeutic agent always involves a preclinical screening stage. During this stage, the pharmacodynamic, pharmacokinetic and toxicological properties of the candidate drug are analysed. The preclinical investigation is based on both in vitro models and in vivo experiments in various animal species [54] . However, due to regulatory developments in the EU [55] , there is currently much promotion of the development of in vitro models, which can accurately indicate in vivo results [56, 57] . In addition to ethical considerations and the 3Rs principle [58] , animal drug testing has certain limitations. While different mammalian species
share key physiological principles, they differ enough to be rather deficient for inter-species pharmacological and toxicological prediction [59] . There is, therefore, increasing emphasis on the development of in vitro tests as critical toxicological tools, capable of complementing and reducing animal testing, particularly at the preclinical screening phase of drug development.
The laser dependency of the spectroscopic properties (fluorescence/Raman) of anthracyclines, discussed in Section 3.3, is also evident when cells treated with DOX are investigated with two different excitation wavelengths. Previous work [60] demonstrated the utility of the Raman spectroscopy modality in the assessment of nuclear accumulation of four anthracyclines in endothelial cells when measurements were conducted with the use of the 488 nm laser line. The maximum of fluorescence for the anthracycline standards (3820-4245 cm -1 , Figure 1S ) coincides with the range in which the increased background is observed in the Raman spectra from anthracycline-treated cells, and, therefore, the fluorescence in this spectral range, observable as a background to the Raman spectrum, is a good marker for the presence of anthracycline in the cells. The integration of spectra obtained from the mapping allows the study of the distribution of the drug in the cell [60] .
Investigations undertaken in the present work with the 785 nm laser line reveal similar information on the distribution of the drug, based, however, on the characteristic doxorubicin Raman marker bands [25] and both approaches are suitable for intracellular tracking of DOX at a subcellular level. However, spectra collected with the use of 785 nm source allow for more specific investigations of the modes of interaction of the drug, as, in the absence of the strong fluorescence background, the molecularly specific vibrational profiles of the drug itself as well as the biochemical environment of the cell can be monitored (Farhane et al. 2015b ).
On the other hand, for fast Raman imaging with better spatial resolution, application of the 488nm laser line is preferable. Here, we present the comparison of spectra collected from cell compartments i.e. nucleus, nucleolus, cytoplasm of control and cells treated with DOX, using the 488 nm laser line as well as 785 nm ( Figure 6 ). Highlighted regions correspond to DOX spectral features : 3820-4245 cm -1 (fluorescence region for the 488 nm laser line), 400-505 cm -1 and 1200-1290 cm -1 (characteristic bands for 785 nm laser line). 
Conclusions
The potential of UV-vis and FT-IR spectroscopies for anthracycline characterization is presented. However, it is argued that Raman spectroscopy is the method of choice for antibiotic study both in the isolated form as well as after incubation with cells. We have demonstrated a strong laser influence on the quality of Raman spectra of anthracyclines.
When the 488 nm laser is used, a strong fluorescence is recorded, but by using 785 nm, characteristic bands of anthracyclines are clearly observed. On the other hand, both laser lines are suitable for in vitro investigation of anthracycline treated cells, although different levels of information are obtained when spectra collected from cell compartments (nucleus, nucleolus, cytoplasm) are analyzed. Ultimately, Raman spectroscopy provides a potential route towards in vitro screening of chemotherapeutic agents, to explore their uptake, nuclear accumulation interaction mechanisms , and subcellular distribution. 
